CVE:SCYB Scythian Biosciences (SCYB) Stock Price, News & Analysis → Are You Positioned For The New Energy Goldrush? (From Wealthpin Pro) (Ad) Free SCYB Stock Alerts C$3.49 -0.22 (-5.93%) (As of 07/25/2018) Add Compare Share Share Today's RangeC$3.46▼C$3.7750-Day RangeC$3.49▼C$3.4952-Week RangeC$1.01▼C$8.61Volume703,164 shsAverage Volume231,491 shsMarket CapitalizationC$102.38 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Scythian Biosciences alerts: Email Address Ad Wealthpin ProAre You Positioned For The New Energy Goldrush?Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy.Click here to get all the information about it. About Scythian BiosciencesScythian Biosciences Corp. engages in the research and development of cannabinoid-based combination drug therapies for the treatment of concussions and traumatic brain injury. It also develops drug candidates for the treatment of gastro-intestinal inflammatory issues. The company is headquartered in Toronto, Canada.Read More SCYB Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SCYB Stock News HeadlinesMay 19, 2024 | finance.yahoo.comSchwab High Yield Bond ETF (SCYB)February 24, 2024 | morningstar.comScryb Inc SCYBSeptember 27, 2023 | ca.finance.yahoo.comScryb Inc. (SCYB.CN)March 18, 2023 | thestreet.comVentrus Biosciences (VTUS) Stock Surges TodayJanuary 5, 2023 | finance.yahoo.comScale Biosciences (ScaleBio) Introduces New Disruptive Single-Cell Profiling and Analysis Solutions, Sets New StandardsJune 3, 2022 | baystreet.caCanadian Jobs to be Presented Next FridaySee More Headlines Receive SCYB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Scythian Biosciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolCVE:SCYB CUSIPN/A CIKN/A Webscythianbio.com Phone+1-416-3669192FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares29,334,000Free FloatN/AMarket CapC$102.38 million OptionableNot Optionable BetaN/A 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Key ExecutivesMr. Rob ReidCEO & DirectorMr. Jonathan James Held (Age 32)Chief Financial Officer Mr. Maghsoud Dariani (Age 65)Chief Scientific Officer Prof. Michael BarnesChief Medical OfficerKey CompetitorsProMetic Life SciencesTSE:PLIFennec PharmaceuticalsTSE:FRXVIVO CannabisCVE:ABCNEmblemCVE:EMCMedicenna TherapeuticsTSE:MDNAView All Competitors SCYB Stock Analysis - Frequently Asked Questions How have SCYB shares performed in 2024? Scythian Biosciences' stock was trading at C$3.49 at the beginning of 2024. Since then, SCYB shares have increased by 0.0% and is now trading at C$3.49. View the best growth stocks for 2024 here. What other stocks do shareholders of Scythian Biosciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other Scythian Biosciences investors own include Cross Timbers Royalty Trust (CRT), Archer-Daniels-Midland (ADM), InfraCap MLP ETF (AMZA), Alliance Resource Partners (ARLP), Brigham Minerals (MNRL), Organigram (OGI), Roku (ROKU), Scythian Biosciences (SCCYF) and Abbott Laboratories (ABT). How do I buy shares of Scythian Biosciences? Shares of SCYB stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (CVE:SCYB) was last updated on 5/31/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceGold Set to EXPLODE!Gold Safe ExchangeDo This Before July 30 2024 To Claim Trump’s Gift Wealthpin ProA once-in-a-century profit opportunity?Digital Mavericks MediaElon Musk’s Final Masterpiece: “X-9840”Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Scythian Biosciences Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.